AtriCure, Inc. (ATRC)
55.14
+1.55
(+2.89%)
USD |
NASDAQ |
Oct 02, 16:00
55.13
-0.01
(-0.02%)
Pre-Market: 20:00
AtriCure Market Cap : 2.805B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.805B |
| October 01, 2026 | 2.726B |
| September 30, 2026 | 2.859B |
| September 29, 2026 | 2.953B |
| September 28, 2026 | 2.971B |
| September 25, 2026 | 2.969B |
| September 24, 2026 | 3.091B |
| September 23, 2026 | 3.049B |
| September 22, 2026 | 2.992B |
| September 21, 2026 | 2.966B |
| September 18, 2026 | 2.955B |
| September 17, 2026 | 3.007B |
| September 16, 2026 | 2.906B |
| September 15, 2026 | 2.860B |
| September 14, 2026 | 2.838B |
| September 11, 2026 | 2.774B |
| September 10, 2026 | 2.694B |
| September 09, 2026 | 2.697B |
| September 08, 2026 | 2.733B |
| September 04, 2026 | 2.620B |
| September 03, 2026 | 2.668B |
| September 02, 2026 | 2.675B |
| September 01, 2026 | 2.488B |
| August 31, 2026 | 2.459B |
| August 28, 2026 | 2.469B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.506B |
| August 26, 2026 | 2.450B |
| August 25, 2026 | 2.476B |
| August 24, 2026 | 2.507B |
| August 21, 2026 | 2.491B |
| August 20, 2026 | 2.415B |
| August 19, 2026 | 2.422B |
| August 18, 2026 | 2.327B |
| August 17, 2026 | 2.277B |
| August 14, 2026 | 2.253B |
| August 13, 2026 | 2.212B |
| August 12, 2026 | 2.216B |
| August 11, 2026 | 2.185B |
| August 10, 2026 | 2.118B |
| August 07, 2026 | 2.105B |
| August 06, 2026 | 2.009B |
| August 05, 2026 | 2.001B |
| August 04, 2026 | 1.984B |
| August 03, 2026 | 1.969B |
| July 31, 2026 | 1.921B |
| July 30, 2026 | 2.042B |
| July 29, 2026 | 2.080B |
| July 28, 2026 | 2.022B |
| July 27, 2026 | 1.901B |
| July 24, 2026 | 1.782B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 168.71B |
| Boston Scientific Corp. | 61.63B |
| AngioDynamics, Inc. | 630.09M |
| Alphatec Holdings, Inc. | 1.531B |
| Baxter International, Inc. | 12.14B |
Market Cap Related Metrics
| PE Ratio | 254.81 |
| PS Ratio | 4.690 |
| Price to Book Value | 5.431 |
| Price to Free Cash Flow | 50.30 |
| Price | 55.14 |
| Earnings Yield | 0.39% |
| Operating PE Ratio | 192.33 |
| Normalized PE Ratio | 238.60 |